Pharma firms explain rationale for combination drugs

NEW DELHI: Pharma firms need to explain the medical rationale for combination drugs while seeking marketingapproval for them, an expert panel set up by the government has recommended. This move is intended to get rid of irrational combination drugs which have flooded the domestic market today. Combination drugs comprise over 46% of the 70,000-crore domestic drug market.

Read the source article at The Economic Times